Natural Killer Cell with CD25 Receptor Attacking Cancer Cells

Unlocking Natural Killer Cells: How CD25 Expression Could Revolutionize Cancer and Infection Therapies

Rhea Morgan in Health & Wellness August 2025 • 4 min read.

"A New Marker for Cytotoxic Activity in Natural Killer Cells"

Natural Killer (NK) cells are a critical part of our immune system, acting as the first line of defense against infections and cancer. They're like the body's rapid response team, quickly identifying and eliminating threats without needing prior exposure. Scientists have been working hard to understand exactly how NK cells work, hoping to harness their power for new therapies.

One of the biggest challenges is finding reliable ways to measure NK cell activity. Current methods are complex and time-consuming, making it difficult to quickly assess how well these cells are functioning. What if there was a simple marker on the surface of NK cells that could tell us how active and effective they are? That's the question driving exciting new research.

A recent study suggests that the CD25 receptor, found on the surface of NK cells, could be just such a marker. Researchers have found a strong correlation between CD25 expression and NK cell cytotoxic activity, meaning that the more CD25 an NK cell has, the better it is at killing target cells. This discovery could revolutionize how we study and utilize NK cells in immunotherapy.

The CD25 Connection: Linking Receptor Expression to NK Cell Function

Natural Killer Cell with CD25 Receptor Attacking Cancer Cells

The study, conducted by researchers at the University of Łódź, Poland, investigated the relationship between CD25 expression and various markers of NK cell activity. They stimulated NK cells with lipopolysaccharide (LPS), a component of bacterial cell walls that triggers an immune response, and then co-cultured them with HeLa cells, a common target cell line used in cancer research. The researchers then measured both CD25 expression and cytotoxic activity.

The team used flow cytometry, a technique that allows scientists to identify and count cells with specific markers on their surface. They found that CD25 expression was exclusively upregulated on CD3-CD56+ NK cells. More importantly, this increased CD25 expression was positively correlated with several key indicators of NK cell cytotoxic function, including:

MTT Assay: A measure of cell viability, indicating the number of dead target cells (r=0.68).
Granzyme B Release: Granzyme B is an enzyme released by NK cells to induce apoptosis (cell death) in target cells (r=0.89).
IL-2 Production: Interleukin-2 (IL-2) is a cytokine that promotes the growth and activity of immune cells, including NK cells (r=0.78).
IFN-γ Production: Interferon-gamma (IFN-γ) is another cytokine that enhances NK cell activity and helps to fight infections (r=0.57).

These findings suggest that CD25 expression is not just a marker of NK cell activation, but also a reliable indicator of their cytotoxic potential and cytokine production. However, the study found no positive correlation between CD25 expression and FasL or caspase-8, other markers associated with NK cell-mediated cytotoxicity, suggesting that CD25 expression might primarily correlate with the granzyme B-mediated pathway.

The Future of NK Cell Therapy: CD25 as a Screening Tool

The discovery of CD25 as a potential marker for NK cell cytotoxic activity opens up exciting possibilities for immunotherapy. It offers a simple and efficient way to screen NK cells for their ability to kill target cells and produce cytokines. This could be invaluable for selecting the most potent NK cells for adoptive cell therapy, a treatment approach where NK cells are collected from a patient, expanded and activated in the lab, and then infused back into the patient to fight cancer or infection.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

What are Natural Killer (NK) cells and why are they important?

Natural Killer (NK) cells are a crucial component of the immune system, acting as the body's first line of defense against infections and cancer. They function as a rapid response team, identifying and eliminating threats without requiring prior exposure, setting them apart from other immune cells that need to learn to recognize threats. Their importance lies in their ability to quickly neutralize threats, preventing infections from spreading and tumors from growing, making them a key target in cancer and infection therapies.

How does CD25 expression relate to the activity of Natural Killer (NK) cells?

The study found a strong correlation between CD25 expression on Natural Killer (NK) cells and their cytotoxic activity. Higher CD25 expression indicates that the NK cell is more effective at killing target cells. Specifically, researchers at the University of Łódź, Poland, found that increased CD25 expression was positively correlated with key indicators of NK cell cytotoxic function, including MTT Assay, Granzyme B Release, IL-2 Production, and IFN-γ Production. This suggests CD25 is not just a marker of activation, but a reliable indicator of the cells' cytotoxic potential.

What specific methods were used to study the link between CD25 and NK cell function?

The research team stimulated Natural Killer (NK) cells with lipopolysaccharide (LPS) and co-cultured them with HeLa cells, a common target cell line. They measured CD25 expression and cytotoxic activity. The primary method used was flow cytometry, a technique that identifies and counts cells based on specific markers on their surface. This allowed them to quantify the level of CD25 expression on the NK cells. They also measured cell viability using the MTT Assay, the release of Granzyme B, and the production of IL-2 and IFN-γ to assess the cells' cytotoxic function.

What are the implications of this research for cancer and infection therapies?

The discovery of CD25 as a marker of Natural Killer (NK) cell cytotoxic activity opens new possibilities for immunotherapy. It allows for a simple and efficient way to screen NK cells for their killing ability and cytokine production, which can be invaluable in selecting the most potent NK cells for adoptive cell therapy. This approach involves collecting NK cells, expanding and activating them in a lab, and then infusing them back into the patient to fight cancer or infection. This makes treatment more precise and potentially more effective.

Besides CD25, what other markers were examined and what was their correlation?

In addition to CD25, the study investigated the relationship between NK cell activity and other markers. However, the research found no positive correlation between CD25 expression and FasL or caspase-8, which are other markers associated with NK cell-mediated cytotoxicity. This suggests that CD25 expression is specifically linked to the granzyme B-mediated pathway, which is one way NK cells induce cell death in target cells. This specificity provides a more focused understanding of CD25's role in NK cell function.